Wednesday, July 4, 2018

Update on Aimovig

A quick update on my 2 month free trial of Aimovig. Remember, this is the first of the new class of migraine preventives - the first drugs ever to have been developed specifically to prevent migraines. They came out of fairly recent research that determined that migraines are not caused by vasodilation as previously believed, but rather are tied to an increase in a specific peptide, or protein, in the brain, (calcitonin gene-related peptide or CGRP). These drugs inhibit the CGRP, thus preventing migraine.

Aimovig is a self-administered, once a month injection. If you are interested, I suggest applying for the 2 month free trial. Amgen will end the injections to your home for free. I have just finished my first month and will receive the second dose in 2 days. So far, I have not seen a reduction in the number of migraine days, but the headaches I have are definitely milder. It is supposed to take as much as three months to experience the full effect of the medication, so I am still hopeful. But I am happy even now as I don't dread the headaches as I used to, and I have zero side effects. I definitely recommend it to all migraine sufferers.